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Background: To assess the risk and severity of IBS in a population of TMD patients.
Materials and Methods: Subjects for the study group were recruited from patients attending the Dental Clinic. 
Health controls (HC) were recruited among patients’ friends and clinic staff. All subjects filled in the RDC/TMD 
questionnaire and the ROME III questionnaire for the diagnosis of IBS. The IBS Severity Scoring System (IBS-
SSS) was used to evaluate the severity of each case of IBS. Categorical variables were compared through the Chi 
square test. The risk of having abdominal pain was analysed using logistic regression.
Results. Twenty-two (46.8%) cases of IBS were diagnosed among TMD patients, whereas only 4 (11.4%) were in 
the HC group. This difference was statistically significant (χ2(1)=11.6; p<.01). The differences in the distribution of 
IBS-SSS were statistically significant (χ2(3)=12.49; p<.05). The regression model resulted statistically significant 
(χ2(5)=24.08; p<.001, R2=.37): abdominal pain was significantly related to nonspecific physical symptoms inde-
pendent of the other variables. 
Conclusions. TMD patients had a greater risk of having IBS compared to HC. TMD patients presented also more 
severe form of IBS than HC. 
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Introduction
Temporomandibular disorders (TMD) include different 
clinical conditions that involve masticatory muscles 
and/or temporomandibular joints (TMJs) (1) presenting 
common symptoms: pain in the area of jaw muscles and/
or the TMJ; limitation or alteration of mandibular mo-
vements and TMJ sounds (2). TMD patients often com-
plain symptoms in other body regions and meet diag-
nostic criteria for other clinical conditions. Associations 
were found between TMD and migraine and chronic 
fatigue syndrome (3), fibromyalgia (4), vulvar vestibu-
litis syndrome (5), anxiety and depressive disorders (6), 
irritable bowel syndrome (IBS) (7–9) and others. Many 
of these disorders are considered as central sensitivity 
syndromes (CSS), in which the phenomenon of central 
sensitization leads to an increase of the excitability of 
neurons in central nociceptive pathways and an inhi-
bition of the descending pain modulatory system (10). 
Muscular subtypes of TMD (i.e. group I of RDC system 
(11) show typical aspects of CSS (3).
IBS is a chronic functional disorder of the lower gas-
trointestinal tract characterized by a group of symptoms 
including chronic abdominal pain or discomfort associa-
ted with altered bowel habits (12). Prevalence of IBS 
was estimated on 11% of the global population. Women 
are two to three times more likely to be diagnosed with 
IBS than men (13). People diagnosed with IBS are usua-
lly younger than 45 years old. IBS was found associated 
to other clinical conditions, like other gastrointestinal 
functional syndromes, migraine, chronic fatigue syn-
drome, chronic pelvic pain, fibromyalgia, depressive 
syndromes and anxiety disorders (14–17). Recently, a 
strong correlation was found between TMD and IBS 
(18): a sample of IBS patients showed a more than three 
times greater risk of TMD compared to controls. In that 
study, no differences in IBS severity was found between 
patients with or without TMD diagnosis. Furthermore, 
no previous studies investigated the severity of IBS in 
TMD patients. The aim of the present study was two-
fold: 1) to assess the risk of IBS in a population of TMD 
patients and 2) to assess the severity of IBS in the same 
population.
Material and Methods
Subjects for the study group were recruited from patients 
attending the Dental Clinic of the University of Ferra-
ra. The inclusion criterion was the presence of at least 
one TMD diagnosis according to RDC criteria (11). Pa-
tients with other orofacial pain diagnosis were excluded. 
Health controls (HC, i.e. without signs and symptoms 
of TMD) were recruited among patients’ friends and 
clinic staff. Enrolment took place between June 2016 
and January 2017. All subjects filled in the RDC/TMD 
questionnaire (11) and the ROME III questionnaire for 
the diagnosis of IBS (12). According to RDC/TMD 
questionnaire, TMD diagnosis was obtained for both the 
physical and psychosocial axis, Axis I and Axis II, res-
pectively. For Axis II, the severity of chronic pain was 
measured using the Graded Chronic Pain Scale (GCPS), 
allowing the categorization of five levels of pain–related 
impairment. Depression and somatization levels were 
evaluated by depression and somatization scales from 
the 90R Symptom Checklist (SCL-90R). According to 
that, patients were classified as having normal, moderate 
or severe impairment levels according to depressive and 
non-specific physical symptoms. Every possible diagno-
sis of IBS was identified through the filling of a specific 
questionnaire and considering the ROME III criteria. 
The IBS Severity Scoring System (IBS-SSS) was used 
to evaluate the severity of each case of IBS. This widely 
accepted scoring system considers the following varia-
bles: current abdominal pain intensity measured through 
a 0-100 visual analogue scale (VAS) and the frequency 
of abdominal pain; current abdominal distension expres-
sed through VAS; intestinal habits satisfaction through 
VAS; degree of interference by IBS pathology in work 
and normal social activities through VAS. Summing 
single VAS scores allowed to classify IBS patients into 
three groups of severity: mild (75 to 175), moderate (175 
to 300) and severe (> 300). 
The study protocol was approved by the local Ethics 
Committee, it is in compliance with the Helsinki Decla-
ration and all subjects gave written informed consent.
A sample of 79 was calculated for a confidence level of 
95% and confidence interval of 10.
Categorical variables were compared through the Chi 
square test. The post-hoc comparison (when applicable) 
was made using z-test for multiple comparisons. The 
risk of having abdominal pain was analysed using lo-
gistic regression. P <.05 was considered as statistically 
significant. SPSS for MAC OS X version 24.0 (SPSS, 
Chicago, IL, United States) was used for data processing 
and analysis.
Results
Forty-seven TMD patients (42 females, mean age 
49.94+/-13.76 years) and 35 healthy controls (HC) (29 
females, mean age 42.40+/-11.44 years) were enrolled 
in the study.
Following the ROME III criteria for the diagnosis of 
IBS, 22 (46.8%) cases of IBS were diagnosed among 
TMD patients, whereas only 4 (11.4%) were in the 
HC group. This difference was statistically significant 
(c2(1)=11.6; p<.01). TMD group had a greater than six 
times risk of having IBS compared to HC (OR=6.82, 
95% CI:2.08-22.38).
The difference in the distribution of GCPS between 
TMD and HC groups was statistically significant 
(c2(4)=53.62, p<.001). There were significant differen-
ces in the distribution of GCPS grade 0, grade II (31.9% 
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vs 5.7%) and grade III (38.3% vs 0%). There was no 
difference regarding to GCPS grade I (19.1% vs. 5.7%) 
and Grade IV (2.1% vs. 0.0%).
No statistically significant difference emerged in the dis-
tribution of depression scores between TMD and HC. 
The difference in the distribution of nonspecific physical 
symptoms (pain items included) between TMD and HC 
groups was statistically significant (c2(2)=11.14; p<.05). 
There were significant differences in the distribution of 
normal (17.0% vs 37.1%) and severe levels (59.6% vs. 
22.9%). There was no difference for moderate levels 
(23.4% vs. 40.0%). The difference in the distribution of 
nonspecific physical symptoms (pain items excluded) 
between TMD and HC groups was statistically signifi-
cant (c2(2)=11.83; p<.05). There were significant diffe-
rences in the distribution of normal (21.3% vs 45.7%) 
and severe levels (57.4% vs. 20.0%). There was no di-
fference for moderate levels (21.3% vs. 34.3%).
The severity of IBS, according to IBS-SSS score, is re-
ported in Fig. 1. The differences in the distribution of 
IBS-SSS were statistically significant (c2(3)=12.49; 
p<.05). There were significant differences in the distri-
bution of moderate (21.3% vs 5.7%) and severe IBS-
SSS (12.8% vs 0%). On the other hand, there was no 
difference for mild IBS-SSS (12.8% vs. 5.7%).
The difference in the distribution of GCPS between sub-
jects with and without IBS was statistically significant 
(c2(4)=14.57, p<.01, Fig. 2). There were significant di-
fferences in the distribution of GCPS grade 0 and grade 
III. No difference was found for depression. The diffe-
rence in the distribution of nonspecific physical symp-
toms (pain items included) between subjects with and 
without IBS was statistically significant (c2(2)=13.74; 
p<.01). There were significant differences in the distri-
bution of normal and severe levels. The difference in 
the distribution of nonspecific physical symptoms (pain 
Fig. 1: Distribution of subjects according to GCPS score. Asterisks indicate significance 
differences (Chi square, p<.05).
Fig. 2: Distribution of subjects according to depression score.
J Clin Exp Dent. 2019;11(9):e802-6.                                                                                                                                                                                          IBS in TMD patients: case-control study
e805
items excluded) between subjects with and without IBS 
was statistically significant (c2(2)=19.75; p<.001, Fig. 
3). There were significant differences in the distribution 
of all levels.
There was a significant correlation between the presen-
ce of facial pain and the presence of abdominal pain. 
However, when regression model was performed, ab-
dominal pain was significantly related only to physical 
symptoms (c2(5)=24.08; p<.001, R2=.37, Table 1). 
Fig. 3: Distribution of subjects according to nonspecific physical symptoms (pain items in-
cluded). Asterisks indicate significance differences (Chi square, p<.05).
B SE Wald df Sig. Exp(B)
Age 0.007 0.024 0.088 1 0.767 1.007
Sex 19.913 11139.75 0.000 1 0.999 444565671.2
Facial pain 0.219 1.116 0.038 1 0.845 1.244
GCPS 0.305 0.395 0.596 1 0.440 1.356
Nonspecific physical symptoms 1.202 0.563 4.56 1 0.033 3.327
Costant -44.595 22279.51 0.000 1 0.998 0.000
Table 1: Logistic regression analysis: abdominal pain by age, sex, facial pain, GCPS and nonspecific physical symptoms.
Dependent variable: abdominal pain.
Discussion
The present results showed that TMD patients had a risk 
of suffering of IBS more than six times greater than HC. 
Analysis for subgroups of TMD diagnosis was not per-
formed because of the small number of subjects in some 
subgroups (the majority of TMD patients being mus-
cular). For Axis II, as expected, TMD patients showed 
higher levels than HC for all the variables (with the ex-
ception of depression).
A difference was found for the distribution of IBS se-
verity in TMD patients. Both moderate and severe for-
ms of IBS were more frequent in TMD patients rather 
than HC. That means that TMD patients not only have 
a higher risk to suffer from IBS, but that IBS is present 
in more severe form in TMD patients. While the higher 
risk of IBS in TMD patients has been established pre-
viously (3,9), this is the first time that such a correlation 
was found between TMD and IBS severity. These re-
sults underlined the complexity of a complete diagnosis 
in TMD patients: they often present symptoms related 
to body regions different from orofacial one (19). This 
consideration lead to clinically important consequence: 
a TMD patient can suffer from other diseases that can be 
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overlooked, not diagnosed and then not treated (8,20). 
The analysis of the distribution of Axis II variables 
according to the diagnosis of IBS revealed some inte-
resting aspects. Excluding depression (that was not sig-
nificant), both GCPS and physical symptoms showed 
significant differences. Subjects with IBS showed higher 
level of chronic pain and physical symptoms than sub-
jects without IBS. Such results underlined the psycho-
social involvement of IBS subjects, and are similar and 
“symmetrical” to previous results (18).
Regression analysis for abdominal pain also revealed so-
mething interesting: after including Axis II variables, the 
only predictor of abdominal pain was nonspecific phy-
sical symptoms. Such a result suggests that rather than 
TMD patients being more prone to IBS (or vice versa), 
it is possible that such patients suffer from a general, 
systemic disorder that expresses in different clinical for-
ms. Such a systemic disorder may involve different body 
regions and systems: in the orofacial region we call it 
“TMD”, in intestinal region we call it “IBS”. It is not 
the first time that the hypothesis of CSS is proposed for 
TMD (10). These results underline one more time the 
importance of routinely using Axis II questionnaires: 
just clinical diagnosis is not enough for completely un-
derstanding a TMD patient, but psychosocial evaluation 
is mandatory. Investigating the overlapping of different 
symptoms and disorders may dramatically help the ma-
nagement of chronic pain patients: indeed, a simulta-
neous approach has been proved to be more effective 
than single therapies (21). Further studies should deeply 
investigate these not yet completely cleared aspects. 
This study presents some limits. Even if the two samples 
are homogeneous for age and gender distribution, they 
both have a small number of subjects. The present de-
sign is a case-control study that is suitable to find an as-
sociation but not a cause-effect relationship. Further stu-
dies with more enrolled subjects and a different design 
(i.e. cohort study) are needed to overcome these limits. 
However, within the above mentioned limits, it is possi-
ble to conclude that:
TMD patients present a greater risk of having IBS com-
pared to controls;
IBS presents in more severe forms in TMD patients ra-
ther than controls;
For a complete evaluation of TMD patients, it is crucial 
to perform Axis II diagnosis.
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